Evidence map›Paper›PMID 31738810›Full record

ArticlePLoS pathogens2019

Kinetics of HTLV-1 reactivation from latency quantified by single-molecule RNA FISH and stochastic modelling.

Michi Miura, Supravat Dey, Saumya Ramanayake, Abhyudai Singh, David S Rueda, Charles R M Bangham

Abstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. HTLV-1-Infected CD4Neurology(R) neuroimmunology & neuroinflammation · 2026
    Article
  2. The mJournal of virology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michi MiuraDepartment of Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0002-6943-3782
Supravat DeyDepartment of Electrical and Computer Engineering, University of Delaware, Newark, Delaware, United States of America.
Saumya RamanayakeDepartment of Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0003-4718-8728
Abhyudai SinghDepartment of Electrical and Computer Engineering, University of Delaware, Newark, Delaware, United States of America.ORCID 0000-0002-1451-2838
David S RuedaDepartment of Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0003-4657-6323
Charles R M BanghamDepartment of Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.

Funding

Consequences and Control of Randomness in Timing of Intracellular EventsR01GM124446 · NIGMS · UNIVERSITY OF DELAWARE · PI SINGH, ABHYUDAI · 2017 to 2020
$914k
Stochastic hybrid systems approach to uncovering cell-size control mechanisms R01GM126557 · NIGMS · UNIVERSITY OF DELAWARE · PI SINGH, ABHYUDAI · 2017 to 2019
$675k
Medical Research Council MC_UP_1102/5Medical Research Council MR/K019090/1Medical Research Council UKRI MC-A658-5TY10NIGMS NIH HHS R01 GM124446NIGMS NIH HHS R01 GM126557Wellcome Trust 100291Wellcome Trust 206292/Z/17/ZWellcome Trust 207477/Z/17/Z
6 · The paper itself

Abstract

The human T cell leukemia virus HTLV-1 establishes a persistent infection in vivo in which the viral sense-strand transcription is usually silent at a given time in each cell. However, cellular stress responses trigger the reactivation of HTLV-1, enabling the virus to transmit to a new host cell. Using single-molecule RNA FISH, we measured the kinetics of the HTLV-1 transcriptional reactivation in peripheral blood mononuclear cells (PBMCs) isolated from HTLV-1+ individuals. The abundance of the HTLV-1 sense and antisense transcripts was quantified hourly during incubation of the HTLV-1-infected PBMCs ex vivo. We found that, in each cell, the sense-strand transcription occurs in two distinct phases: the initial low-rate transcription is followed by a phase of rapid transcription. The onset of transcription peaked between 1 and 3 hours after the start of in vitro incubation. The variance in the transcription intensity was similar in polyclonal HTLV-1+ PBMCs (with tens of thousands of distinct provirus insertion sites), and in samples with a single dominant HTLV-1+ clone. A stochastic simulation model was developed to estimate the parameters of HTLV-1 proviral transcription kinetics. In PBMCs from a leukemic subject with one dominant T-cell clone, the model indicated that the average duration of HTLV-1 sense-strand activation by Tax (i.e. the rapid transcription) was less than one hour. HTLV-1 antisense transcription was stable during reactivation of the sense-strand. The antisense transcript HBZ was produced at an average rate of ~0.1 molecules per hour per HTLV-1+ cell; however, between 20% and 70% of HTLV-1-infected cells were HBZ-negative at a given time, the percentage depending on the individual subject. HTLV-1-infected cells are exposed to a range of stresses when they are drawn from the host, which initiate the viral reactivation. We conclude that whereas antisense-strand transcription is stable throughout the stress response, the HTLV-1 sense-strand reactivation is highly heterogeneous and occurs in short, self-terminating bursts.

Indexed as

Cells, CulturedGene Expression Regulation, ViralHTLV-I InfectionsHumansHuman T-lymphotropic virus 1In Situ Hybridization, FluorescenceKineticsLeukocytes, MononuclearSingle-Cell AnalysisStochastic ProcessesViral ProteinsVirus ActivationVirus LatencyVirus ReplicationViral Proteins

Identifiers

PMID31738810
PMCPMC6886867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.